Who are Crescent International?
Crescent International was established as a strategic response to Brexit, aiming to capitalise on growth opportunities in the international market. Based in Malta, Crescent International currently possesses more than 30 EU approved marketing authorisations. The company is currently in the process of applying for the Maltese Medicines and Healthcare products Regulatory Agency (MIA) certification.
Moving forward, Crescent International intends on registering the remaining Crescent Pharma licenses and exploring the potential for distributing Crescent Products in the European Union (EU) market. By leveraging our extensive regulatory expertise and established network, we aim to expand our reach and enhance our market position.
Crescent International was set up in 2020 with its Headquarters located in Malta.
EU Licences 30, and EU IP parked in Malta as part of Brexit and international expansion strategy.
Geographical gateway to Africa and international expansion both inside and outside the EU.
Sea, Air and Road export courier partnership.
Medicines Licence applied for and EU batch release capabilities